Phathom Pharmaceuticals (Nasdaq: PHAT) is a biopharmaceutical company committed to transforming the treatment landscape for people suffering from gastrointestinal (GI) diseases related to acid. We are a team of highly driven pharmaceutical professionals who are passionate about our mission to address unmet needs for patients and improve their quality of life. By ensuring all voices are heard, holding ourselves accountable to be equitable and just, and authentically supporting the people and communities impacted by our work, we strive to create a sense of inclusion and belonging. We are looking for self-motivated, creative problem solvers who are excited by the idea of working in a fast-paced start-up environment and contributing to our growth.
| Website | http://phathompharma.com |
| Revenue | $29.7 million |
| Employees | 439 (340 on RocketReach) |
| Founded | 2018 |
| Address | 100 Campus Drive Suite 102, Florham Park, New Jersey 07932, US |
| Phone | +1 877-742-8466 |
| Technologies |
JavaScript
,
HTML
,
PHP
+36 more
(view full list)
|
| Industry | Biotechnology Research |
| Keywords | Acid Reflux Treatment, Biopharmaceutical Research, Clinical Trials, Fda Approval, Pharmaceutical Development, Drug Discovery, Prescription Drugs, Health Technology, Therapeutics, Pharmaceutical, Human Health, Biotechnology, Medical Research |
| Competitors | Novo Nordisk, Bristol Myers Squibb, Amgen, Gilead Sciences, Pfizer, Lilly India, Merck & Co., Inc., AbbVie, Sanofi, Regeneron +42 more (view full list) |
Looking for a particular Phathom Pharmaceuticals employee's phone or email?
The Phathom Pharmaceuticals annual revenue was $29.7 million in 2026.
Steven Basta is the CEO of Phathom Pharmaceuticals.
340 people are employed at Phathom Pharmaceuticals.
Phathom Pharmaceuticals is based in Florham Park, New Jersey.